External Source

Amivantamab For Nsclc With Met Exon 14 Skipping Mutations

2021 1:18
Synopsis
Alexander Spira, MD, PhD, FACP, Virginia Cancer Specialists, Fairfax, VA, discusses the use of amivantamab, a bispecific ...

You Might Also Like

Update from CHRYSALIS: amivantamab in patients with NSCLC with MET exon 14 skipping mutation 3:01
Update From Chrysalis: Amivantamab In Patients With Nsclc Wi...
2022
METalmark: amivantamab and capmatinib in advanced NSCLC 1:05
Metalmark: Amivantamab And Capmatinib In Advanced Nsclc
2024
Amivantamab in patients with EGFR Ex20ins-mutated NSCLC 2:28
Amivantamab In Patients With Egfr Ex20ins-mutated Nsclc
2023
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC 4:27
Amivantamab Shows Robust Efficacy In Post-platinum Therapy P...
2023
Recent approvals in the NSCLC treatment landscape 1:56
Recent Approvals In The Nsclc Treatment Landscape
2022
Gregory J. Riely Provides an Overview of MET Exon 14 Skipping Mutations in Lung Cancer 1:06
Gregory J. Riely Provides An Overview Of Met Exon 14 Skippin...
2015
Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve EGFRm NSCLC 16:45
Amivantamab In Combination With Lazertinib For Osimertinib-r...
2021
MARIPOSA: resistance mechanisms of amivantamab & lazertinib in NSCLC 3:12
Mariposa: Resistance Mechanisms Of Amivantamab & Lazertinib ...
2025
METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer 3:40
Metex14 Sas (met Exon 14 Skipping Alterations) In Non-small ...
2020
Detecting the MET Exon 14 Skipping Mutations in NSCLC 1:11
Detecting The Met Exon 14 Skipping Mutations In Nsclc
2020
Phase III MARIPOSA: amivantamab + lazertinib vs osimertinib in EGFR-mutated NSCLC 3:17
Phase Iii Mariposa: Amivantamab + Lazertinib Vs Osimertinib ...
2023
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.